ZHU.TO BMO Equal Weight US Health Care Index ETF
Issuer
BMO
Inception
Feb 12, 2019
AUM
C$20.7M
Expense ratio
0.40%
Yield
0.43%
Asset class
Equity
Holdings
0
Last price
C$55.90
The BMO Equal Weight US Health Care Index ETF aims to closely mirror the returns of the Solactive Equal Weight US Health Care Index, after factoring in its operating costs. This is achieved by the Fund acquiring and maintaining positions in the underlying index's member securities, weighted identically to their representation within that benchmark.
+25.8%
2025-11-13low 41.47 · high 56.682026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| ZHU.TO | +6.0% | +11.8% | +25.9% | +25.8% | +14.1% | +4.1% |
| Equity average (793 funds) | +0.2% | -0.5% | +8.4% | +10.1% | +12.0% | +5.7% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$15K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| MDGL Madrigal Pharmaceuticals, Inc. | 0.83% | $35.0M | $7.0M |
| COO The Cooper Companies, Inc. | 0.93% | $1.9M | $0 |
| ELAN Elanco Animal Health Incorporated | 1.12% | $1.0M | $100K |
| ALNY Alnylam Pharmaceuticals, Inc. | 0.62% | $543K | $399K |
| PODD Insulet Corporation | 1.05% | $162K | $0 |
| BSX Boston Scientific Corporation | 0.98% | $100K | $0 |
| CRL Charles River Laboratories International, Inc. | 1.23% | $3K | $20.3M |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA Moderna, Inc. | 1.77% |
| 2 | GKOS Glaukos Corporation | 1.44% |
| 3 | IDXX IDEXX Laboratories, Inc. | 1.35% |
| 4 | MTD Mettler-Toledo International Inc. | 1.34% |
| 5 | LLY Eli Lilly and Company | 1.30% |
| 6 | HCA HCA Healthcare, Inc. | 1.29% |
| 7 | VTRS Viatris Inc. | 1.29% |
| 8 | TEM Tempus AI, Inc. | 1.27% |
| 9 | ISRG Intuitive Surgical, Inc. | 1.27% |
| 10 | UTHR United Therapeutics Corporation | 1.26% |
| 11 | RVTY Revvity, Inc. | 1.26% |
| 12 | WST West Pharmaceutical Services, Inc. | 1.25% |
| 13 | GEHC GE HealthCare Technologies Inc. | 1.24% |
| 14 | EXEL Exelixis, Inc. | 1.24% |
| 15 | BTSG BrightSpring Health Services, Inc. | 1.24% |
| 16 | MCK McKesson Corporation | 1.24% |
| 17 | CRL Charles River Laboratories International, Inc. | 1.23% |
| 18 | EW Edwards Lifesciences Corporation | 1.22% |
| 19 | A Agilent Technologies, Inc. | 1.21% |
| 20 | EHC Encompass Health Corporation | 1.21% |
| 21 | REGN Regeneron Pharmaceuticals, Inc. | 1.20% |
| 22 | TMO Thermo Fisher Scientific Inc. | 1.20% |
| 23 | BDX Becton, Dickinson and Company | 1.20% |
| 24 | UHS Universal Health Services, Inc. | 1.20% |
| 25 | QIA.DE Qiagen N.V. | 1.20% |
| 26 | MDLN MEDLINE INC | 1.19% |
| 27 | ABBV AbbVie Inc. | 1.19% |
| 28 | WAT Waters Corporation | 1.19% |
| 29 | BIIB Biogen Inc. | 1.19% |
| 30 | STE STERIS plc | 1.18% |
| 31 | LH Labcorp Holdings Inc. | 1.18% |
| 32 | DHR Danaher Corporation | 1.17% |
| 33 | MEDP Medpace Holdings, Inc. | 1.17% |
| 34 | GILD Gilead Sciences, Inc. | 1.16% |
| 35 | CAH Cardinal Health, Inc. | 1.16% |
| 36 | NBIX Neurocrine Biosciences, Inc. | 1.16% |
| 37 | HUM Humana Inc. | 1.15% |
| 38 | VEEV Veeva Systems Inc. | 1.15% |
| 39 | THC Tenet Healthcare Corporation | 1.15% |
| 40 | ZBH Zimmer Biomet Holdings, Inc. | 1.13% |
| 41 | RPRX Royalty Pharma plc | 1.13% |
| 42 | DGX Quest Diagnostics Incorporated | 1.13% |
| 43 | ZTS Zoetis Inc. | 1.13% |
| 44 | ENSG The Ensign Group, Inc. | 1.13% |
| 45 | ALGN Align Technology, Inc. | 1.12% |
| 46 | ELAN Elanco Animal Health Incorporated | 1.12% |
| 47 | 0Y6X.L Medtronic plc | 1.12% |
| 48 | AMGN Amgen Inc. | 1.11% |
| 49 | CI The Cigna Group | 1.11% |
| 50 | BBIO BridgeBio Pharma, Inc. | 1.10% |
| 51 | COR Cencora, Inc. | 1.09% |
| 52 | SYK Stryker Corporation | 1.09% |
| 53 | CNC Centene Corporation | 1.09% |
| 54 | ANTM Elevance Health, Inc. | 1.09% |
| 55 | RMD ResMed Inc. | 1.08% |
| 56 | PFE Pfizer Inc. | 1.07% |
| 57 | IQV IQVIA Holdings Inc. | 1.06% |
| 58 | JNJ Johnson & Johnson | 1.06% |
| 59 | BAX Baxter International Inc. | 1.06% |
| 60 | UNH UnitedHealth Group Incorporated | 1.05% |
| 61 | PODD Insulet Corporation | 1.05% |
| 62 | ABT Abbott Laboratories | 1.04% |
| 63 | TECH Bio-Techne Corporation | 1.04% |
| 64 | VRTX Vertex Pharmaceuticals Incorporated | 1.04% |
| 65 | JAZZ Jazz Pharmaceuticals plc | 1.04% |
| 66 | PEN Penumbra, Inc. | 1.03% |
| 67 | DVA DaVita Inc. | 1.03% |
| 68 | HSIC Henry Schein, Inc. | 1.02% |
| 69 | MRK Merck & Co., Inc. | 1.01% |
| 70 | NTRA Natera, Inc. | 1.01% |
| 71 | ILMN Illumina, Inc. | 1.01% |
| 72 | SOLV Solventum Corporation | 1.00% |
| 73 | INCY Incyte Corporation | 1.00% |
| 74 | GH Guardant Health, Inc. | 0.99% |
| 75 | INSM Insmed Incorporated | 0.99% |
| 76 | SMMT Summit Therapeutics Inc. | 0.98% |
| 77 | BSX Boston Scientific Corporation | 0.98% |
| 78 | BMY Bristol-Myers Squibb Company | 0.97% |
| 79 | HALO Halozyme Therapeutics, Inc. | 0.96% |
| 80 | DXCM DexCom, Inc. | 0.95% |
| 81 | COO The Cooper Companies, Inc. | 0.93% |
| 82 | BMRN BioMarin Pharmaceutical Inc. | 0.91% |
| 83 | RVMD Revolution Medicines, Inc. | 0.89% |
| 84 | KRYS Krystal Biotech, Inc. | 0.89% |
| 85 | CYTK Cytokinetics, Incorporated | 0.83% |
| 86 | MDGL Madrigal Pharmaceuticals, Inc. | 0.83% |
| 87 | AXSM Axsome Therapeutics, Inc. | 0.75% |
| 88 | CORT Corcept Therapeutics Incorporated | 0.69% |
| 89 | ALNY Alnylam Pharmaceuticals, Inc. | 0.62% |
| 90 | ARWR Arrowhead Pharmaceuticals, Inc. | 0.59% |
| 91 | IONS Ionis Pharmaceuticals, Inc. | 0.50% |
| 92 | ZHU.TO Cash | 0.07% |
Sector breakdown
Healthcare100.0%
Country breakdown
United States100.0%
Distributions
| Date | Per unit |
|---|---|
| Dec 30, 2025 | C$0.2400 |
| Dec 30, 2024 | C$0.2500 |
| Dec 27, 2023 | C$0.4000 |
| Dec 28, 2022 | C$0.1800 |
| Dec 29, 2021 | C$0.0600 |
| Dec 29, 2020 | C$0.1500 |
| Dec 27, 2019 | C$0.0600 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in ZHU.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error